Emily S. I. Kunkel
Papers
1
Total Citations
69
H-Index
1
About
Dr. Emily S. I. Kunkel is a leading researcher in telestroke medicine and acute stroke care, with a focus on expanding access to life-saving treatments in underserved and community settings. Her landmark 2013 study, "Intravenous Tissue Plasminogen Activator Administration in Community Hospitals Facilitated by Telestroke Service" (69 citations), demonstrated that telestroke networks can safely and effectively deliver IV-tPA—the gold-standard therapy for ischemic stroke—to patients in hospitals lacking on-site neurologists. This work directly addressed a critical gap in stroke care, showing that telemedicine can overcome geographic and resource barriers, dramatically increasing treatment rates from the national average of 3-5%. Dr. Kunkel’s contributions have been instrumental in shaping telemedicine protocols and stroke systems of care, influencing clinical guidelines and hospital networks worldwide. Her research continues to drive equity in acute neurological care, ensuring that patients in rural or community hospitals receive the same timely, expert-guided treatment as those in major stroke centers.
Research Focus
Key Achievements
Top Papers
- 1